Northwest Biotherapeutics, Inc.

Immune cells, namely cells for medical or veterinary use; Biotechnology preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Medical preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators; Derivatives and modulators of immune cells, namely, vaccines, proteins, peptides, enzymes, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for medical or veterinary use; Vaccines

Pharmaceutical preparations for use in the treatment of Cancer

Pharmaceutical preparations for use in the treatment of cancer; "BIOTHERAPEUTICS"

Cancer immunotherapies

Pharmaceutical preparations, namely human monoclonal antibodies for use in the treatment of cancer

Pharmaceutical and biological research and product development services with respect to treatments and therapies for the treatment of cancer

Vaccines

medical diagnostic reagents for in vivo imaging